SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES WERE EXCLUDED FROM CALCULATION OF DILUTED NET LOSS PER SHARE (Details) (Parenthetical) - Share Exchange Agreement [Member] - Warrant [Member] |
Jun. 29, 2021
shares
|
|---|---|
| Warrants to purchase shares | 1,098,830 |
| CreoMed Inc [Member] | |
| Warrants to purchase shares | 400,000 |
| Ahmet Demir Bingol [Member] | |
| Warrants to purchase shares | 698,830 |